Division of Infectious Diseases

AIDS Clinical Trials Unit lands renewal of NIH funding

Vanderbilt University’s AIDS Clinical Trials Unit (ACTU) has received a seven-year grant renewal from the National Institutes of Health (NIH).

Human and Helicobacter co-evolution

HIV cell

HIV’s impact on B cells

Understanding how HIV infection affects immune system B cells may guide strategies for vaccine development.

Aronoff to lead Division of Infectious Diseases

David Aronoff, M.D., has been named the new director of Vanderbilt University Medical Center’s Division of Infectious Diseases.

Preserving antibiotic arsenal for TB

Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB.

Vanderbilt researchers work to balance flu vaccine debate

Research in the last two years to examine the effectiveness of the influenza vaccine has raised public doubt about the flu shot’s effectiveness. But two Vanderbilt researchers co-wrote an editorial in the Journal of the American Medical Association (JAMA) recently to help balance the current debate.

1 8 9 10 11